In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa.
AUTOR(ES)
Ng, W W
RESUMO
The in vitro activities of Ro 17-2301 and aztreonam against 191 Pseudomonas aeruginosa isolates were compared with those of five other beta-lactam antibiotics. Both compounds showed activities comparable to that of ceftazidime and were bactericidal. They were as effective against gentamicin-or carbenicillin-resistant isolates as against susceptible ones.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180169Documentos Relacionados
- Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
- Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.
- Activities of New Beta-Lactam Antibiotics Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis
- Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.
- In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.
